Mirae Asset Global Investments
SNDX icon

Mirae Asset Global Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Mirae Asset Global Investments’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.6K Sell
3,963
-637
-14% -$13.2K ﹤0.01% 1267
2026
Q1 		$107K Buy
4,600
+377
+9% +$8.19K ﹤0.01% 1167
2025
Q4 		$88.7K Buy
4,223
+893
+27% +$15.6K ﹤0.01% 1281
2025
Q3 		$51.2K Buy
3,330
+6
+0.2% +$79 ﹤0.01% 1337
2025
Q2 		$31.1K Buy
3,324
+468
+16% +$5.15K ﹤0.01% 1328
2025
Q1 		$37.6K Buy
2,856
+12
+0.4% +$169 ﹤0.01% 1296
2024
Q4 		$36.3K Sell
2,844
-234
-8% -$4K ﹤0.01% 1320
2024
Q3 		$58.1K Buy
3,078
+541
+21% +$11.2K ﹤0.01% 1277
2024
Q2 		$51.6K Sell
2,537
-37,731
-94% -$790K ﹤0.01% 1243
2024
Q1 		$893K Sell
40,268
-6,629
-14% -$148K ﹤0.01% 1601
2023
Q4 		$1.01M Buy
46,897
+4,705
+11% +$72.3K ﹤0.01% 1613
2023
Q3 		$613K Buy
42,192
+2,700
+7% +$51.1K ﹤0.01% 1783
2023
Q2 		$821K Buy
39,492
+615
+2% +$12.8K ﹤0.01% 1688
2023
Q1 		$821K Buy
38,877
+13,430
+53% +$334K ﹤0.01% 1643
2022
Q4 		$648K Buy
25,447
+1,957
+8% +$45.6K ﹤0.01% 1739
2022
Q3 		$565K Buy
23,490
+7,255
+45% +$163K ﹤0.01% 1801
2022
Q2 		$313K Buy
+16,235
New +$270K ﹤0.01% 1967

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return

Mirae Asset Global Investments's SNDX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Syndax Pharmaceuticals (SNDX) stake by 14% in Q2 2026, selling an estimated $13.2K and leaving 3,963 shares worth $86.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Mirae Asset Global Investments first reported a position in SNDX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.01M in Q4 2023. 67 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Mirae Asset Global Investments held 3,963 shares of Syndax Pharmaceuticals worth $86.6K as of Q2 2026.
  • Mirae Asset Global Investments sold 637 Syndax Pharmaceuticals shares in Q2 2026, an estimated $13.2K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1267 holding.
  • Mirae Asset Global Investments first reported a position in Syndax Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Syndax Pharmaceuticals position peaked at $1.01M in Q4 2023.
  • 67 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.